PATENT CLAIM ANALYSIS

Application Number: 16224140
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-08
Patent Classification: ["540", "456000"]

Abstract:
The present invention provides methods for obtaining purified rapamycin derivatives, including purified Biolimus A9. A crystalline form of Biolimus A9 is also described.

Claim (Index 42):
The method of  claim 40 , wherein the X-ray powder diffraction pattern shows 25 or more diffraction peaks at or around the angles (2\u03b8) selected from the group consisting of 5.00\u00b0, 7.06\u00b0, 9.22\u00b0, 10.07\u00b0, 10.50\u00b0, 11.94\u00b0, 12.71\u00b0, 13.15\u00b0, 14.73\u00b0, 16.33\u00b0, 16.80\u00b0, 17.07\u00b0, 18.01\u00b0, 18.57\u00b0, 19.42\u00b0, 19.81\u00b0, 20.16\u00b0, 20.44\u00b0, 20.93\u00b0, 21.55\u00b0, 22.29\u00b0, 22.58\u00b0, 23.92\u00b0, 24.26\u00b0, 24.83\u00b0, 25.17\u00b0, 26.32\u00b0, 27.48\u00b0, 28.60\u00b0, and 32.28\u00b0.

Metadata:
- Claim Count in Document: 53.0
- Percentile: 98.0
- Lexical Diversity: 1.18182
- Patent Class: 540.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14853711', '15422593', '14804714', '16197037', '13497416']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7227831979667123
- 35 USC 102 Novelty (BERT): 0.5439660944107426
- Combined Prediction Score: 0.7049014876111154
- Mean Citation Score: 263.926648
- Max Citation Score: 383.7347
- Similarity Product: 351.84764214063887

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test